Inhibition of Rho kinase: the next hopeful salvo in the long war against sepsis?
Department of Surgery, Michigan State University, Lansing, MI 48912, USA. chet.morrison@hc.msu.edu
Chet A
CA
Morrison
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives*; D000818:Animals; D003106:Colon / Q000187:drug effects*; D019446:Endotoxemia / Q000188:drug therapy*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D054460:rho-Associated Kinases / Q000037:antagonists & inhibitors*
D008070:Lipopolysaccharides; D047428:Protein Kinase Inhibitors; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D054460:rho-Associated Kinases